Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
REDWOOD CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq:LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2023 after the close of trading on Wednesday, February 21, 2024. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Related news for (LUNG)
- Pulmonx Reports First Quarter 2025 Financial Results
- Don’t Miss Out: MoBot’s Latest Stock Updates 02/20/25 11:00 AM
- Today’s Top Performers: MoBot’s Market Review 02/20/25 10:00 AM
- Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
- 24/7 Market News Snapshot 19 February, 2025 – Pulmonx Corporation Common Stock (NASDAQ:LUNG)